In the last 12 months, insiders at CVRx, Inc. ($CVRX) filed 142 transactions with the SEC: 13 open-market purchases totaling $1,692,001 and 12 sales totaling $779,331. Net insider sentiment: net buying.
CVRx, Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Nielsen Kirk G. (Not found) — 8 transactions totaling $1,037,142
- JOHNSON & JOHNSON (Not found) — 3 transactions totaling $546,310
- Hykes Kevin (PRES & CEO) — 9 transactions totaling $336,316
- Jain Mudit K. (Not found) — 8 transactions totaling $308,152
- VERRASTRO PAUL (CHIEF MKTG & STRAT OFFICER) — 20 transactions totaling $174,434
View all SEC Filings for CVRx, Inc. (CVRX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Adamson Philip B. | Chief Medical Officer | A | Common Stock | 41000 | $0.00 | 62,840.0000 | 26,084,709 | 187.73% | 0.16% |
| Feb. 27, 2026 | Adamson Philip B. | Chief Medical Officer | A | Stock Option (right to buy) | 62000 | $0.00 | 62,000.0000 | 26,084,709 | 9999.99% | 0.24% |
| March 2, 2026 | Adamson Philip B. | Chief Medical Officer | S | Common Stock | 1262 | $7.90 | 61,578.0000 | 26,084,709 | 2.01% | 0.00% |
| March 2, 2026 | Morrison Gregory | CHIEF HUMAN RESOURCES OFFICER | A | Stock Option (right to buy) | 154500 | $0.00 | 154,500.0000 | 26,084,709 | 9999.99% | 0.59% |
| March 2, 2026 | Morrison Gregory | CHIEF HUMAN RESOURCES OFFICER | A | Common Stock | 34000 | $0.00 | 34,000.0000 | 26,084,709 | 9999.99% | 0.13% |
| Feb. 27, 2026 | Hykes Kevin | PRES & CEO | A | Stock Option (right to buy) | 238000 | $0.00 | 238,000.0000 | 26,084,709 | 9999.99% | 0.91% |
| Feb. 27, 2026 | John Robert Allen | Chief Revenue Officer | A | Common Stock | 35000 | $0.00 | 90,000.0000 | 26,084,709 | 63.64% | 0.13% |
| March 2, 2026 | John Robert Allen | Chief Revenue Officer | S | Common Stock | 3964 | $7.90 | 86,036.0000 | 26,084,709 | 4.40% | 0.02% |
| Feb. 27, 2026 | John Robert Allen | Chief Revenue Officer | A | Stock Option (right to buy) | 52000 | $0.00 | 52,000.0000 | 26,084,709 | 9999.99% | 0.20% |
| Feb. 27, 2026 | Binkowski Brent | CHIEF OPERATING OFFICER | A | Common Stock | 15000 | $0.00 | 31,600.0000 | 26,084,709 | 90.36% | 0.06% |
| Feb. 27, 2026 | Binkowski Brent | CHIEF OPERATING OFFICER | A | Stock Option (right to buy) | 23000 | $0.00 | 23,000.0000 | 26,084,709 | 9999.99% | 0.09% |
| Feb. 27, 2026 | Hykes Kevin | PRES & CEO | A | Common Stock | 159000 | $0.00 | 292,000.0000 | 26,084,709 | 119.55% | 0.61% |
| March 2, 2026 | Hykes Kevin | PRES & CEO | S | Common Stock | 7763 | $7.90 | 284,237.0000 | 26,084,709 | 2.66% | 0.03% |
| Feb. 27, 2026 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A | Common Stock | 45000 | $0.00 | 61,835.0000 | 26,084,709 | 267.30% | 0.17% |
| March 2, 2026 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S | Common Stock | 1284 | $7.90 | 60,551.0000 | 26,084,709 | 2.08% | 0.00% |
| Feb. 27, 2026 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A | Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 26,084,709 | 9999.99% | 0.26% |
| Feb. 27, 2026 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | A | Common Stock | 61000 | $0.00 | 98,447.0000 | 26,084,709 | 162.90% | 0.23% |
| March 2, 2026 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | S | Common Stock | 1744 | $7.90 | 96,703.0000 | 26,084,709 | 1.77% | 0.01% |
| Feb. 27, 2026 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 26,084,709 | 9999.99% | 0.35% |
| Feb. 20, 2026 | Jain Mudit K. | Not found | P | Common Stock | 46800 | $6.36 | 985,833.0000 | 26,084,709 | 4.98% | 0.18% |
| Feb. 18, 2026 | Jain Mudit K. | Not found | P | Common Stock | 600 | $4.64 | 939,033.0000 | 26,084,709 | 0.06% | 0.00% |
| Nov. 12, 2025 | JOHNSON & JOHNSON | Not found | S | Common Stock | 1000 | $10.00 | 4,049,898.0000 | 26,168,562 | 0.02% | 0.00% |
| Nov. 7, 2025 | JOHNSON & JOHNSON | Not found | S | Common Stock | 200 | $10.00 | 4,050,898.0000 | 26,168,562 | 0.00% | 0.00% |
| Nov. 6, 2025 | JOHNSON & JOHNSON | Not found | S | Common Stock | 52332 | $10.21 | 4,051,098.0000 | 26,168,562 | 1.28% | 0.20% |
| Aug. 11, 2025 | Binkowski Brent | CHIEF OPERATING OFFICER | A | Common Stock | 16600 | $0.00 | 16,600.0000 | 26,071,316 | 9999.99% | 0.06% |
| Aug. 11, 2025 | Binkowski Brent | CHIEF OPERATING OFFICER | A | Stock Option (right to buy) | 74900 | $0.00 | 74,900.0000 | 26,071,316 | 9999.99% | 0.29% |
| June 3, 2025 | SHADAN MARTHA | Not found | A | Stock Option (right to buy) | 19554 | $0.00 | 19,554.0000 | 25,876,062 | 9999.99% | 0.08% |
| June 3, 2025 | Nielsen Kirk G. | Not found | A | Stock Option (right to buy) | 19554 | $0.00 | 19,554.0000 | 25,876,062 | 9999.99% | 0.08% |
| June 3, 2025 | Jain Mudit K. | Not found | A | Stock Option (right to buy) | 19554 | $0.00 | 19,554.0000 | 25,876,062 | 9999.99% | 0.08% |
| June 3, 2025 | SLATTERY JOSEPH P | Not found | A | Stock Option (right to buy) | 19554 | $0.00 | 19,554.0000 | 25,876,062 | 9999.99% | 0.08% |
| June 3, 2025 | Hill, Mitch C. | Not found | A | Stock Option (right to buy) | 19554 | $0.00 | 19,554.0000 | 25,876,062 | 9999.99% | 0.08% |
| June 3, 2025 | Ballinger Kevin J. | Not found | A | Stock Option (right to buy) | 19554 | $0.00 | 19,554.0000 | 25,876,062 | 9999.99% | 0.08% |
| May 15, 2025 | Nielsen Kirk G. | Not found | P | Common Stock | 10966 | $5.45 | 1,910,134.0000 | 25,876,062 | 0.58% | 0.04% |
| May 14, 2025 | Nielsen Kirk G. | Not found | P | Common Stock | 61200 | $5.23 | 1,899,168.0000 | 25,876,062 | 3.33% | 0.24% |
| May 13, 2025 | Nielsen Kirk G. | Not found | P | Common Stock | 101413 | $5.29 | 1,837,968.0000 | 25,876,062 | 5.84% | 0.39% |
| May 12, 2025 | Nielsen Kirk G. | Not found | P | Common Stock | 25200 | $4.79 | 1,736,555.0000 | 25,876,062 | 1.47% | 0.10% |
| May 12, 2025 | Jain Mudit K. | Not found | P | Common Stock | 1500 | $4.66 | 938,283.0000 | 25,876,062 | 0.16% | 0.01% |
| May 13, 2025 | Jain Mudit K. | Not found | P | Common Stock | 150 | $5.26 | 938,433.0000 | 25,876,062 | 0.02% | 0.00% |
| May 12, 2025 | Hykes Kevin | PRES & CEO | P | Common Stock | 5000 | $4.84 | 133,000.0000 | 25,876,062 | 3.91% | 0.02% |
| Feb. 28, 2025 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A | Common Stock | 16000 | $0.00 | 16,835.0000 | 22,596,229 | 1916.17% | 0.07% |
| Feb. 28, 2025 | Hykes Kevin | PRES & CEO | A | Common Stock | 98000 | $0.00 | 128,000.0000 | 22,596,229 | 326.67% | 0.43% |
| Feb. 28, 2025 | Hykes Kevin | PRES & CEO | A | Stock Option (right to buy) | 148000 | $0.00 | 148,000.0000 | 22,596,229 | 9999.99% | 0.65% |
| Feb. 28, 2025 | John Robert Allen | Chief Revenue Officer | A | Common Stock | 55000 | $0.00 | 55,000.0000 | 22,596,229 | 9999.99% | 0.24% |
| Feb. 28, 2025 | John Robert Allen | Chief Revenue Officer | A | Stock Option (right to buy) | 38000 | $0.00 | 38,000.0000 | 22,596,229 | 9999.99% | 0.17% |
| Feb. 28, 2025 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | A | Common Stock | 22000 | $0.00 | 37,447.0000 | 22,596,229 | 142.42% | 0.10% |
| Feb. 28, 2025 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 33000 | $0.00 | 33,000.0000 | 22,596,229 | 9999.99% | 0.15% |
| Feb. 28, 2025 | Adamson Philip B. | Chief Medical Officer | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 22,596,229 | 9999.99% | 0.09% |
| Feb. 28, 2025 | Adamson Philip B. | Chief Medical Officer | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 22,596,229 | 9999.99% | 0.13% |
| Feb. 28, 2025 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A | Stock Option (right to buy) | 24000 | $0.00 | 24,000.0000 | 22,596,229 | 9999.99% | 0.11% |
| Nov. 19, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M | Common Stock | 2500 | $5.14 | 3,305.0000 | 22,783,337 | 310.56% | 0.01% |
| Nov. 19, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M | Stock Option (right to buy) | 2500 | $0.00 | 73,306.0000 | 22,783,337 | 3.30% | 0.01% |
| Nov. 21, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | G | Common Stock | 1040 | $0.00 | 835.0000 | 22,783,337 | 55.47% | 0.00% |
| Nov. 19, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S | Common Stock | 1430 | $13.58 | 1,875.0000 | 22,783,337 | 43.27% | 0.01% |
| Sept. 3, 2024 | Hill, Mitch C. | Not found | A | Stock Option (right to buy) | 36136 | $0.00 | 36,136.0000 | 21,628,542 | 9999.99% | 0.17% |
| Sept. 3, 2024 | Ballinger Kevin J. | Not found | A | Stock Option (right to buy) | 36136 | $0.00 | 36,136.0000 | 21,628,542 | 9999.99% | 0.17% |
| Aug. 15, 2024 | SLATTERY JOSEPH P | Not found | P | Common Stock | 3000 | $8.10 | 30,645.0000 | 21,628,542 | 10.85% | 0.01% |
| Aug. 8, 2024 | SLATTERY JOSEPH P | Not found | P | Common Stock | 3000 | $8.24 | 27,645.0000 | 21,628,542 | 12.17% | 0.01% |
| Aug. 6, 2024 | SLATTERY JOSEPH P | Not found | P | Common Stock | 2500 | $9.09 | 24,645.0000 | 21,628,542 | 11.29% | 0.01% |
| Aug. 5, 2024 | Hykes Kevin | PRES & CEO | P | Common Stock | 30000 | $8.36 | 30,000.0000 | 21,628,542 | 9999.99% | 0.14% |
| July 31, 2024 | Hykes Kevin | PRES & CEO | A | Stock Option (right to buy) | 180000 | $0.00 | 180,000.0000 | 21,628,542 | 9999.99% | 0.83% |
| June 27, 2024 | John Robert Allen | Chief Revenue Officer | A | Stock Option (right to buy) | 122192 | $0.00 | 122,192.0000 | 21,232,009 | 9999.99% | 0.58% |
| June 4, 2024 | Behbahani Ali | Not found | A | Stock Option (right to buy) | 27250 | $0.00 | 27,250.0000 | 21,232,009 | 9999.99% | 0.13% |
| June 4, 2024 | SHADAN MARTHA | Not found | A | Stock Option (right to buy) | 27250 | $0.00 | 27,250.0000 | 21,232,009 | 9999.99% | 0.13% |
| June 4, 2024 | Jain Mudit K. | Not found | A | Stock Option (right to buy) | 27250 | $0.00 | 27,250.0000 | 21,232,009 | 9999.99% | 0.13% |
| June 4, 2024 | SLATTERY JOSEPH P | Not found | A | Stock Option (right to buy) | 27250 | $0.00 | 27,250.0000 | 21,232,009 | 9999.99% | 0.13% |
| June 4, 2024 | Nielsen Kirk G. | Not found | A | Stock Option (right to buy) | 27250 | $0.00 | 27,250.0000 | 21,232,009 | 9999.99% | 0.13% |
| June 4, 2024 | Nielsen Kirk G. | Not found | A | Stock Option (right to buy) | 20961 | $0.00 | 20,961.0000 | 21,232,009 | 9999.99% | 0.10% |
| June 4, 2024 | SLATTERY JOSEPH P | Not found | A | Stock Option (right to buy) | 20961 | $0.00 | 20,961.0000 | 21,232,009 | 9999.99% | 0.10% |
| June 4, 2024 | Jain Mudit K. | Not found | A | Stock Option (right to buy) | 20961 | $0.00 | 20,961.0000 | 21,232,009 | 9999.99% | 0.10% |
| June 4, 2024 | Behbahani Ali | Not found | A | Stock Option (right to buy) | 20961 | $0.00 | 20,961.0000 | 21,232,009 | 9999.99% | 0.10% |
| June 4, 2024 | SHADAN MARTHA | Not found | A | Stock Option (right to buy) | 20961 | $0.00 | 20,961.0000 | 21,232,009 | 9999.99% | 0.10% |
| March 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | M | Common Stock | 404 | $0.24 | 1,078.0000 | 20,754,375 | 59.94% | 0.00% |
| March 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | M | Stock Option (right to buy) | 151 | $0.00 | 0.0000 | 20,754,375 | 100.00% | 0.00% |
| March 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | M | Stock Option (right to buy) | 404 | $0.00 | 0.0000 | 20,754,375 | 100.00% | 0.00% |
| March 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | M | Stock Option (right to buy) | 379 | $0.00 | 0.0000 | 20,754,375 | 100.00% | 0.00% |
| March 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | M | Common Stock | 379 | $0.24 | 674.0000 | 20,754,375 | 128.47% | 0.00% |
| March 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | M | Common Stock | 151 | $0.24 | 1,229.0000 | 20,754,375 | 14.01% | 0.00% |
| Feb. 23, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | G | Common Stock | 1650 | $0.00 | 805.0000 | 20,754,375 | 67.21% | 0.01% |
| Feb. 20, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S | Common Stock | 2545 | $21.91 | 2,455.0000 | 20,754,375 | 50.90% | 0.01% |
| Feb. 20, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M | Common Stock | 5000 | $5.14 | 5,000.0000 | 20,754,375 | 9999.99% | 0.02% |
| Feb. 20, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M | Stock Option (right to buy) | 5000 | $0.00 | 75,806.0000 | 20,754,375 | 6.19% | 0.02% |
| Feb. 12, 2024 | Hykes Kevin | PRES & CEO | A | Stock Option (right to buy) | 360000 | $0.00 | 360,000.0000 | 20,754,375 | 9999.99% | 1.73% |
| Feb. 2, 2024 | Palmer Craig E. | SVP, U.S. SALES | A | Stock Option (right to buy) | 31600 | $0.00 | 31,600.0000 | 20,754,375 | 9999.99% | 0.15% |
| Feb. 2, 2024 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 55500 | $0.00 | 55,500.0000 | 20,754,375 | 9999.99% | 0.27% |
| Feb. 2, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A | Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 20,754,375 | 9999.99% | 0.15% |
| Feb. 2, 2024 | Yared Nadim | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 22050 | $0.00 | 22,050.0000 | 20,754,375 | 9999.99% | 0.11% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 158 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 118 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 165 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 189 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 237 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 1264 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.01% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 758 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 142 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 758 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 300 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 758 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 489 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 758 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 85 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 23 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | Not found | J | Stock Option (Right to Buy) | 71 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Jan. 29, 2024 | Yared Nadim | CHIEF EXECUTIVE OFFICER | M | Common Stock | 4055 | $0.24 | 24,310.0000 | 20,754,375 | 20.02% | 0.02% |
| Jan. 29, 2024 | Yared Nadim | CHIEF EXECUTIVE OFFICER | M | Common Stock | 1945 | $0.24 | 26,255.0000 | 20,754,375 | 8.00% | 0.01% |
| Jan. 29, 2024 | Yared Nadim | CHIEF EXECUTIVE OFFICER | M | Stock Option (right to buy) | 4055 | $0.00 | 0.0000 | 20,754,375 | 100.00% | 0.02% |
| Jan. 29, 2024 | Yared Nadim | CHIEF EXECUTIVE OFFICER | M | Stock Option (right to buy) | 1945 | $0.00 | 29,092.0000 | 20,754,375 | 6.27% | 0.01% |
| Dec. 28, 2023 | SLATTERY JOSEPH P | Not found | M | Stock Option (right to buy) | 174 | $0.00 | 0.0000 | 20,801,350 | 100.00% | 0.00% |
| Dec. 28, 2023 | SLATTERY JOSEPH P | Not found | M | Stock Option (right to buy) | 96 | $0.00 | 7,590.0000 | 20,801,350 | 1.25% | 0.00% |
| Dec. 28, 2023 | SLATTERY JOSEPH P | Not found | M | Stock Option (right to buy) | 1456 | $0.00 | 0.0000 | 20,801,350 | 100.00% | 0.01% |
| Dec. 28, 2023 | SLATTERY JOSEPH P | Not found | M | Stock Option (right to buy) | 224 | $0.00 | 0.0000 | 20,801,350 | 100.00% | 0.00% |
| Dec. 28, 2023 | SLATTERY JOSEPH P | Not found | M | Common Stock | 96 | $3.96 | 22,145.0000 | 20,801,350 | 0.44% | 0.00% |
| Dec. 28, 2023 | SLATTERY JOSEPH P | Not found | M | Common Stock | 174 | $1.19 | 22,049.0000 | 20,801,350 | 0.80% | 0.00% |
| Dec. 28, 2023 | SLATTERY JOSEPH P | Not found | M | Common Stock | 1456 | $0.24 | 21,875.0000 | 20,801,350 | 7.13% | 0.01% |
| Dec. 28, 2023 | SLATTERY JOSEPH P | Not found | M | Common Stock | 224 | $0.24 | 20,419.0000 | 20,801,350 | 1.11% | 0.00% |
| Dec. 14, 2023 | Behbahani Ali | Director | M | Stock Option (right to buy) | 316 | $0.00 | 0.0000 | 20,801,350 | 100.00% | 0.00% |
| Dec. 14, 2023 | Behbahani Ali | Director | M | Common Stock | 316 | $0.24 | 316.0000 | 20,801,350 | 9999.99% | 0.00% |
| Oct. 16, 2023 | Galle Liz | VP OF GLOBAL CLINICAL RESEARCH | M | Stock Option (right to buy) | 778 | $0.00 | 0.0000 | 20,801,350 | 100.00% | 0.00% |
| Oct. 16, 2023 | Galle Liz | VP OF GLOBAL CLINICAL RESEARCH | M | Common Stock | 778 | $0.24 | 778.0000 | 20,801,350 | 9999.99% | 0.00% |
| Sept. 18, 2023 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | M | Common Stock | 5335 | $3.96 | 15,447.0000 | 20,711,850 | 52.76% | 0.03% |
| Sept. 18, 2023 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | M | Stock Option (right to buy) | 527 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| Sept. 18, 2023 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | M | Stock Option (right to buy) | 5335 | $0.00 | 11,732.0000 | 20,711,850 | 31.26% | 0.03% |
| Sept. 18, 2023 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | M | Common Stock | 527 | $0.24 | 10,112.0000 | 20,711,850 | 5.50% | 0.00% |
| Sept. 15, 2023 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | J | Common Stock | 3495575 | $0.00 | 0.0000 | 20,711,850 | 100.00% | 16.88% |
| Aug. 3, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S | Common Stock | 628 | $18.55 | 0.0000 | 20,711,850 | 100.00% | 0.00% |
| July 31, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M | Common Stock | 3750 | $5.14 | 3,750.0000 | 20,711,850 | 9999.99% | 0.02% |
| July 31, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S | Common Stock | 1122 | $17.49 | 2,628.0000 | 20,711,850 | 29.92% | 0.01% |
| Aug. 2, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | G | Common Stock | 2000 | $0.00 | 628.0000 | 20,711,850 | 76.10% | 0.01% |
| July 31, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M | Stock Option (right to buy) | 3750 | $5.14 | 80,806.0000 | 20,711,850 | 4.43% | 0.02% |
| June 5, 2023 | Behbahani Ali | Director | A | Stock Option (right to buy) | 12012 | $0.00 | 12,012.0000 | 20,693,224 | 50.00% | 0.06% |
| June 5, 2023 | SHADAN MARTHA | Not found | A | Stock Option (right to buy) | 12012 | $0.00 | 12,012.0000 | 20,693,224 | 9999.99% | 0.06% |
| June 5, 2023 | Hykes Kevin | Not found | A | Stock Option (right to buy) | 12012 | $0.00 | 12,012.0000 | 20,693,224 | 9999.99% | 0.06% |
| June 5, 2023 | SLATTERY JOSEPH P | Not found | A | Stock Option (right to buy) | 12012 | $0.00 | 12,012.0000 | 20,693,224 | 9999.99% | 0.06% |
| June 5, 2023 | Jain Mudit K. | Not found | A | Stock Option (right to buy) | 12012 | $0.00 | 12,012.0000 | 20,693,224 | 9999.99% | 0.06% |
| June 5, 2023 | Nielsen Kirk G. | Not found | A | Stock Option (right to buy) | 12012 | $0.00 | 12,012.0000 | 20,693,224 | 9999.99% | 0.06% |
| May 16, 2023 | Palmer Craig E. | SVP, U.S. SALES | M | Common Stock | 295 | $0.24 | 295.0000 | 20,693,224 | 9999.99% | 0.00% |
| May 16, 2023 | Palmer Craig E. | SVP, U.S. SALES | M | Stock Option (right to buy) | 295 | $0.00 | 0.0000 | 20,693,224 | 100.00% | 0.00% |
| Jan. 18, 2023 | Palmer Craig E. | SVP, U.S. SALES | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 20,532,838 | 9999.99% | 0.19% |
| Jan. 18, 2023 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 20,532,838 | 9999.99% | 0.34% |
| Jan. 18, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 20,532,838 | 9999.99% | 0.22% |
| Jan. 18, 2023 | Yared Nadim | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 20,532,838 | 9999.99% | 0.97% |
| Jan. 18, 2023 | Galle Liz | VP OF GLOBAL CLINICAL RESEARCH | A | Stock Option (right to buy) | 26000 | $0.00 | 26,000.0000 | 20,532,838 | 9999.99% | 0.13% |
| Jan. 11, 2023 | Yared Nadim | CHIEF EXECUTIVE OFFICER | G | Common Stock | 7080 | $0.00 | 45,420.0000 | 20,532,838 | 13.49% | 0.03% |